Ann: AD-214 pathway to IPF efficacy studies, page-17

  1. 35 Posts.
    lightbulb Created with Sketch. 39
    Hmmm maybe they should see if they can pivot to a fibrotic condition driven by overexpression of CXCR4 in the liver. Not sure if one exists, but if it does then we would be set
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $2.142M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $5.6K 2.8M

Buyers (Bids)

No. Vol. Price($)
22 23616803 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 9545560 17
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.